Zobrazeno 1 - 6
of 6
pro vyhledávání: '"59"'
Autor:
Prayuth Sudathip, Aungkana Saejeng, Nardlada Khantikul, Thannikar Thongrad, Suravadee Kitchakarn, Rungniran Sugaram, Cheewanan Lertpiriyasuwat, Darin Areechokchai, Deyer Gopinath, David Sintasath, Pascal Ringwald, Sathapana Naowarat, Niparueradee Pinyajeerapat, Maria Dorina Bustos, Jui A. Shah
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-16 (2021)
Abstract Background Integrated drug efficacy surveillance (iDES) was formally introduced nationally across Thailand in fiscal year 2018 (FY2018), building on a history of drug efficacy monitoring and interventions. According to the National Malaria E
Externí odkaz:
https://doaj.org/article/7da4b53b40c44a08a244d98169e4fd56
Autor:
Stella Wanjiku Gikunju, Eric L. Agola, Raphael Omusebe Ondondo, Johnson Kinyua, Francis Kimani, Angelle Desiree LaBeaud, Indu Malhotra, Charles King, Kelvin Thiong’o, Francis Mutuku
Publikováno v:
Malaria Journal, Vol 19, Iss 1, Pp 1-7 (2020)
Abstract Background Prevention and treatment of malaria during pregnancy is crucial in dealing with maternal mortality and adverse fetal outcomes. The World Health Organization recommendation to treat all pregnant women with sulfadoxine-pyrimethamine
Externí odkaz:
https://doaj.org/article/1189adc7753945aa8f526297cedcd437
Autor:
Carter Tamar E, Warner Megan, Mulligan Connie J, Existe Alexander, Victor Yves S, Memnon Gladys, Boncy Jacques, Oscar Roland, Fukuda Mark M, Okech Bernard A
Publikováno v:
Malaria Journal, Vol 11, Iss 1, p 275 (2012)
Abstract Background Malaria caused by Plasmodium falciparum infects roughly 30,000 individuals in Haiti each year. Haiti has used chloroquine (CQ) as a first-line treatment for malaria for many years and as a result there are concerns that malaria pa
Externí odkaz:
https://doaj.org/article/2051cf4739554a8eaebdb3fae960e39d
Publikováno v:
Malaria Journal, Vol 10, Iss 1, p 388 (2011)
Abstract Background Understanding the geographical distribution of drug resistance of Plasmodium falciparum is important for the effective treatment of malaria. Drug resistance has previously been inferred mainly from records of clinical resistance.
Externí odkaz:
https://doaj.org/article/110334dfc18942969f5b68231efd5b44
Autor:
Jemila Mint Deida, Yacoub Ould Khalef, Emal Mint Semane, Mohamed Salem Ould Ahmedou Salem, Hervé Bogreau, Leonardo Basco, Ali Ould Mohamed Salem Boukhary, Rachida Tahar
Publikováno v:
Malaria Journal, Vol 17, Iss 1, Pp 1-7 (2018)
Abstract Background Plasmodium vivax is the predominant malaria species in northern Mauritania. Molecular data on P. vivax isolates circulating in West Africa are scarce. The present study analysed molecular markers associated with resistance to anti
Externí odkaz:
https://doaj.org/article/d6b7b51472e445c2ae0c17cf18fc91ed
Autor:
Tobias O. Apinjoh, Regina N. Mugri, Olivo Miotto, Hanesh F. Chi, Rolland B. Tata, Judith K. Anchang-Kimbi, Eleanor M. Fon, Delphine A. Tangoh, Robert V. Nyingchu, Christopher Jacob, Roberto Amato, Abdoulaye Djimde, Dominic Kwiatkowski, Eric A. Achidi, Alfred Amambua-Ngwa
Publikováno v:
Infectious Diseases of Poverty, Vol 6, Iss 1, Pp 1-10 (2017)
Abstract Background Drug resistance is one of the greatest challenges of malaria control programmes, with the monitoring of parasite resistance to artemisinins or to Artemisinin Combination Therapy (ACT) partner drugs critical to elimination efforts.
Externí odkaz:
https://doaj.org/article/7c4a470766704ead9f8b4079d4854d77